Embecta Corp.
NASDAQ: EMBC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Devdatt Kurdikar
- Employees
- 2,000
- Headquarters
- Parsippany, United States
- IPO year
- 2022
- Market cap
- $183.9M
- Website
- https://www.embecta.com
Loading EMBC…
Loading profile data…Frequently asked questions about EMBC
What does Embecta Corp. (EMBC) do?
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to...
Where does EMBC trade?
Embecta Corp. (EMBC) trades on the NASDAQ Global Select.
What sector is EMBC in?
Embecta Corp. (EMBC) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Embecta Corp.?
Devdatt Kurdikar is the chief executive officer of Embecta Corp. (EMBC).
Where is Embecta Corp. headquartered?
Embecta Corp. is headquartered in United States.
Does EMBC pay a dividend?
Yes — Embecta Corp. (EMBC) paid a trailing twelve-month dividend of USD 0.46 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did EMBC go public?
Embecta Corp. (EMBC) completed its initial public offering in 2022.